APNA 26th Annual Conference Session 1044: November 7, 2012
|
|
- Mildred Morrison
- 5 years ago
- Views:
Transcription
1 Disclosure Financial Disclosure: Shionogi Inc., this speaker has no other conflict of interest to disclosure. Identify key symptoms of autism spectrum disorders (ASD) Outline proposed changes for diagnosis of ASD in DSM 5 Review scope of impact of ASD on child/adolescent and family functioning Examine the evidence of varied psychopharmacologic treatments for children and adolescents with ASD Contrast risk (side effects)versus benefit (efficacy) of varied psychopharmacologic agents used with children and adolescents with ASD Waiting room meet and greet 11 year old mixed ethnicity male Presenting symptoms: Mood instability, crying, whining, withdrawal Regression (toileting), sleep dysruption, suicidal thoughts Developmental backdrop IQ normal to intelligent range, home schooled, only child, cultural and familial concerns Mom Speaking quite adult Sebastian is her friend Source of pride Marital concerns Parenting challenges History of mental health care History of school challenges History of depression Dad Distant, Chinese High emotion Works a lot, travels a lot Very invested in achievement Extended family who travels to states Mother describes as labile Disengaged from treatment What do I do about these developmental concerns? How do I help this mom? How will I help this child? To what extent? What about family work? Carbray 1
2 Start Lexapro Connected with Autism group Encouraged mother to explore supports Referred mother for therapy Restrained myself Follow up Interfaced with school Follow up: Cycling of mood Family work Social network Strengths based work Language building Addition of Lamictal Education/symptom tracking Neurodevelopmental disorder with core domains: impaired social interaction/ communication, restricted repetitive behaviors and interests 1 IN 88, UP FROM 1 IN 155 IN 2008 Boys 3 4X more than Girls Detection rates are lower than prevalence 44% of PCPs report caring for at least 10 children with ASD; however, only 8% routinely screen Autistic Disorders Asperger s Syndrome Childhood Disintegrative Disorder Rett syndrome Pervasive developmental disorder Trend towards spectrum Exclusion of Retts syndrome Autistic Disorder: merges childhood disintegrative disorder, Asperger syndrome, pervasive developmental disorder NOS Criteria for autistic disorder Social/communication deficits (social interaction, communication) Fixed interests/repetitive behaviors (restricted interests) Deficits in nonverbal and verbal communication Lack of social reciprocity Lack of peer relationships 2 out of three required for fixed interests criteria Stereotypic behaviors or unusual sensory symptoms Adherence to routines Restricted interests Carbray 2
3 Misdiagnosis is common More so in African Americans Stress on families is significant Burden of care is heavy Educational systems catching up to need high functioning form of autism difficulty interacting socially, repeat behaviors, and often are clumsy Motor milestones may be delayed. The condition appears to be more common in boys than in girls. difficulty socially above average intelligence may excel in fields such as computer programming and science There is no delay in their cognitive development, ability to take care of themselves, or curiosity about their environment. Comorbidity Abnormal eye contact Aloofness Failure to turn when called by name Failure to use gestures to point or show Lack of interactive play Lack of interest in peers 9 10% or up to 70% 41% two or more disorders Social anxiety, ADHD, ODD, most common Dual diagnosis 10% 91% Presentation masked by poor communication skillsreliance on caregivers Symptoms mistaken for aberrant behaviors Profound> greater incident than mild, moderate, severe 20 30% develop epilepsy by adulthood LD, ADHD, Tourettes Disorder, Dual diagnosis 10% 91% Presentation masked by poor communication skillsreliance on caregivers Symptoms mistaken for aberrant behaviors Profound> greater incident than mild, moderate, severe Carbray 3
4 Fewer Support networks Increased experience of loss, rejection, isolation Low self esteem Lack of Control Over ones Life Poor ability to manage stress Poor problem solving/conflict resolution skills Biological vulnerabilities ADOS ASRS CARS GARS 2 PDD Assessment Clinician observation, parent report of social affect, repetitive behaviors Core symptom control Aggression/irritability ADHD like symptoms Repetitive behaviors Will not help developmental concerns unless if co morbid Thomas Antidepressants Fluoxetine (Prozac) 8 and older Sertraline (Zoloft) 6 and older for OCD only Escitolopram (Lexapro) for MDD only Fluvoxamine (Luvox) 8 and older for OCD (Clomipramine)Anafranil 10 and older for OCD Mood stabilizers Valproic Acid (Depakote) 2 and older for seizures Tegretol Any age for seizures Trileptal 4 and older Lithium Carbonate (Eskalith, Lithobid) 12 and older Stimulants Methylphenidate (Ritalin, Concerta, Metadate ER, CD, Methylin, Daytrana, Focalin, Focalin XR, Ritalin SR and LA) 6 and older Dextroamphetamine (Dexedrine, Dextrostat) 3 and older Amphetamines (Adderall) 3 and older (Adderall XR) Lisdexamfetamine dimesylate 6 and older (Vyvanse) Non Stimulants Atomexetine (Strattera) 6 and older Alpha Agonists: Clonidine ( Kapvay), Guanfacine(Intuniv) 6 and older Atypicals Risperidone (Risperal) 6 and older Aripriprazole (Abilify) 10 and older for bipolar mania and mixed episodes; 5 to 16 for irritability associated with autism Ziprasidone (Geodon) 13 and older for schizophrenia; 10 and older for bipolar disorder, manic or mixed episodes; 13 to 17 for schizophrenia and bipolar Quetiepine (Seroquel) 13 and older for schizophrenia; 18 and older for bipolar disorder; for treatment of manic and mixed episodes of bipolar disorder Zyprexa (Olanzapine) 18 and older; ages as second line treatment for manic or mixed episodes of bipolar disorder and schizophrenia Haldol Ages 3 and older for psychosis Others: Orap Tourettes 12 and older Desmopressin (DDAVP ) Nocturesis/enuresis 6 and older Medications do not always work with ASD kids as they do in neurotypical children Side effects more prominent Positive effects less pronounced Work best in comorbid cases Irritability ADHD Repetitive Behaviors Carbray 4
5 MOST STUDIED LESS STUDIED ANTIPSYCHOTICS MOOD STABILIZERS Atypicals FDA approved: Risperal (3 RCTS), Abilify Olanzapine, Quitiepine, Ziprasidone, Clozapine Typicals Haldol, Chlorpromazine, Fluphenazine SSRIs Citalopram, Fluoxetine, Fluvoxamine Alpha agonists Guanfacine, Clonidine Mood stabilizers Lithium, Valproic Acid, Lamotrogine Psychostimulants (associated with implsivity and hyperactivity) Risperdal: Most efficacy studies (irritability)high risk of weight gain Abilify: Efficacy with 20% less weight gain Geodon: probably effective, cardiac arrythmias Typicals: TD, movement D/O Lithium: helpful for mania like symptoms Depakote: mixed Lamotrogine:? (hyperactivity or insomnia possible) Response best when symptoms are like Bipolar: irritabile+hyperactive+ mood labile STIMULANTS A2 AGONISTS OVERLAP WITH OTHER DISORDERS (RULE OUT MEDICAL PROBLEMS!) Disappointing trials More sensitive to side effectsmost common agitation, depressed mood, agression Less effect on attention, hyperactivity, impulsivity than non ASD children Typical response: 60 70%, those with ASDs 24% Methylphenidate demonstrated efficacy Clonidine, Guanfacine Clonidine (mixed), Guanfacine (effective) Decreased irritability Side effects: sedation, irritability, sleep disturbance, constipation Kapvay, Intuniv Straterra Effective OCD SSRIs Large study found Celexa to be no better than placebo Poorly tolerated dry mouth, GI upset, anxiety Prozac effective Mood Stabilizers Some promise (Depakote) Risperdal effective ANXIETY RDOC. LESS EFFICACY PROMISING FUTURES? Celexa, Luvox, Prozac, Luvox Depressive or anxious symptoms Can increase impulsivity, insomnia, behavioral activation A note on benzos Antianxiety agents Stimulants SSRIs with repetitive behaviors unless there is co morbid OCD Most studied does not offer best efficacy (case of secretin) Guanfacine (irritability) Depakote (repetitive behaviors) More money into ASD research and pharma Carbray 5
6 Food Hypersensitivities Diet balance (carbs and proteins) Omega 3 fatty acids Probiotics St. John s Wart Melatonin Management of electronic media Exercise Acupuncture Diagnosis: specific symptom criteria met Clinical significance: symptoms result in distress or disability Functional Impairment across three domains: body, activity, participation Developmental context Correlations between number of symptoms and extent of functional impairment (separation anxiety highest) It effects our whole life. Giving up normal family activities and outings. Lack of spontaneity or flexibility in family life. Lack of personal social activities. Stress surrounding the marital relationship. Difficulties in maintaining employment or pursuing outside activities. Educate the sibling about the consequences of autism Organize activities exclusively for the sibling Involve the sibling whenever possible in activities with the child with autism Higher levels of stress related to parenting incompetence and role restrictions Increased symptoms of depression Low sense of self efficacy Feelings of guilt about not doing enough for the TD child vs. the child with autism Different parenting cognitions about the child with autism and the TD child Deb Keen, Donna Couzens, Sandy Muspratt, and Sylvia Rodger (2010) 2 4 year olds in two different groups Professional Intervention (17 total) DVD Intervention (22 total) Meirsschaut, M, Roeyers, H, Warreyn, P (2010). Parenting in families with a child with autism spectrum disorder and a typically developing child: Mother s experiences and cognitions. Research in Autism Spectrum Disorders. 4, Slides Carbray 6
7 1. Professional support was most effective when assisting parents to understand and reframe child s behavior to be viewed as positive vs. changing parent perceptions about the parenting role 2. Majority of DVD group had difficult putting aside time to complete activity sheets and to watch the actual DVD 3. The way the intervention was given benefited parents with handling stress and competence was linked with professional input with individualization of the information given. 4. Fathers and mothers differed in their response to participating early in the intervention Distress higher amongst those with internalizing disorders Functional impairment higher among those with externalizing disroders Family interference>anxiety, ODD, Depression Educational interference>adhd, CD, Substance abuse Peer interference= Studied previous and current range of: Educational interventions Therapy interventions Medical intervention CAM interventions 84 families or preschool aged children with autism spectrum disorders Used previously 40 Used currently 30 per week) >4 20 per week) >2 and <4 10 per week) >1 and <2 0 per week) >0.5 and <1 per week) <0.5 per week) NA Carter, M, Roberts, J, Williams, K, Evans, D, Parmenter, T, Silove, N, Clark, T, Warren, A (2011). Interventions used with an Australian sample of preschool children with autism spectrum disorders. Research in Autism Spectrum Disorders. 5, Carter, M, Roberts, J, Williams, K, Evans, D, Parmenter, T, Silove, N, Clark, T, Warren, A (2011). Interventions used with an Australian sample of preschool children with autism spectrum disorders. Research in Autism Spectrum Disorders. 5, Carbray 7
8 Books Barber, K. (2011). The Social and Life Skills Menu: A Skill Building Workshop for Adolescents with Autism Spectrum Disorders Beytien, A. (2011), Autism Every Day: Over 150 Strategies Lived and Learned by a professional Autism Consultant with 3 Sons on the Spectrum Gray C., & Attwood, T. (2010), The New Social Story Book Martin A., Scahill L., & Cratochvil C. (2010), Pediatric Psychopharmacology Matson, J.L. (2010), Applied Behavior Analysis for Children with Autism Spectrum Disorders National Institute of Mental Health and Smith, S. (2012), Autism: Causes, Symptoms, Signs, Diagnosis, and Treatments Everything You Need to Know About Autism Sher, B. (20o9), Early Intervention Games: Fun, Joyful Ways to Develop Social and Motor Skills in Children with Autism Spectrum or Sensory Processing Disorders Smith, T. (2011), Making Inclusion Work for Students with Autism Spectrum Disorders: An Evidence Based Guide Zysk, V. (2010), 1001 Great Ideas for Teaching and Raising Children with Autism or Asperger s Web Reources society.org/ Carter, EW, Sisco, LG, Chung, YC, Stanton-chapman, T (2010). Peer interactions of students with intellectual disabilities and/or autism: a map of the intervention literature. Research & Practice for Persons with Severe Disabilities, 35 (3-4), Dosreis S, Weiner CL, Johnson L, Newschaffer CJ. Autism spectrum disorder screening and management practices among general pediatric providers. J Dev Behav Pediatr. 2006;27:S88 S94 Johnson, CR, Handen, BL<, Zimmer, M, Sacco, K, Turner, K (2011). Effects of gluten free/casein free diet in young children with autism: a pilot study. Journal of Developmental and Physical Disabilities, 23, Johnson, N, Frenn, M., Feetham, S., and Simpson, P (2011). Autism Spectrum Disorder: Parenting Stress, Family Functioning and Health-Related Quality of Life. Families, Systems, & Health, 29 (3), McGuinty, E, Armstrong, D, Nelson, J, Sheeler, S (2011) Externalizing metaphors: anxiety and high functioning autism. Journal of child and Adolescent Psychiatric Nursing, 25 (9-16. Carter, M, Roberts, J, Williams, K, Evans, D, Parmenter, T, Silove, N, Clark, T, Warren, A (2011). Interventions used with an Nazeer, A. (2011). Psychopharmacology of autistic spectrum disorders Australian sample of preschool children with autism spectrum in children and adolescents. Pediatric Clinics of North America, 58, disorders. Research in Autism Spectrum Disorders. 5, Meirsschaut, M, Roeyers, H, Warreyn, P (2010). Parenting in Ravindran, N, Meyers, BJ (2011). Cultural influences on perceptions of health, illness, families with a child with autism spectrum disorder and a typically and disability: a review and focus on autism. developing child: Mother s experiences and cognitions. Research Journal of Child Family Studies, 21( in Autism Spectrum Disorders. 4, Robb, A. (2011). Managing irritability and aggression in autism spectrum Keen, D, Couzens, D, Muspratt, S, Rodger, S (2010). The effects disorder in children and adolescents. Developmental Disabilities Research of a parent-focused intervention for children with a recent Reviews, 16, diagnosis of autism spectrum disorder on parenting stress and competence. Research in Austim Spectrum Disorders, 4, 229- Williamson, E.D, and Martin, A. (2010). Psychotropic medications in 241. autism: practical considerations for parents. Journal of Autism and Developmental Disorders. 14, **Google clipart used throughout this presentation*8 Carbray 8
Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children
Judges Reference Table for the Psychotropic Medication Utilization Parameters for Foster Children Stimulants for treatment of ADHD Preschool (Ages 3-5 years) Child (Ages 6-12 years) Adolescent (Ages 13-17
More informationPsychiatric Medications. Positive and negative effects in the classroom
Psychiatric Medications Positive and negative effects in the classroom Teaching the Medicated Child Beverly Bryant, M.D. Hattiesburg Clinic 9/17/14 Introduction According to the National Survey of Children
More informationMedications and Children Disorders
Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for
More informationSchedule FDA & literature based indications
Psychotropic Medication List Recommended dosages are intended to serve only as a guide for children. Recommended doses are literature based. Clinicians should consult package insert of medications for
More informationMedications in Autism: What We Know and Don't Know
Medications in Autism: What We Know and Don't Know Jeremy Veenstra-VanderWeele, M.D. Mortimer D. Sackler, M.D., Associate Professor Center for Autism and the Developing Brain Sackler Institute for Developmental
More informationAutism: Improving Health Care Outcomes
AUTISM AWARESS CONFERENCE Lewis County Autism Coalition 23 September 2011 Autism: Improving Health Care Outcomes Glenn C. Tripp, M.D. Developmental Behavioral Pediatrics Medical Director, Developmental
More informationAutism/Pervasive Developmental Disorders Update. Kimberly Macferran, MD Pediatric Subspecialty for the Primary Care Provider December 2, 2011
Autism/Pervasive Developmental Disorders Update Kimberly Macferran, MD Pediatric Subspecialty for the Primary Care Provider December 2, 2011 Overview Diagnostic criteria for autism spectrum disorders Screening/referral
More information6/22/2012. Co-morbidity - when two or more conditions occur together. The two conditions may or may not be causally related.
Autism Spectrum Disorders and Co-existing Mental Health Issues By Dr. Karen Berkman Objective To present an overview of common psychiatric conditions that occur in persons with autism spectrum disorders
More informationMedically Accepted Indications for Pediatric Use of Psychotropic Medications by
Key: White Background: Medically Accepted Indication Yellow Backgroun: Medically Accepted Indication Status Not Ascertained Orange Background: Pediatric Indication cited, but not supported Red Background:
More informationThe Mental Health and Wellbeing of Children and Adolescents who are affected by Autism and Related Disorders
The Mental Health and Wellbeing of Children and Adolescents who are affected by Autism and Related Disorders Charles Cartwright, M.D Director: YAI Autism Center March 2013 Autism Spectrum Defined by the
More informationA Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer
A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.
More informationOhio Psychotropic Medication Quality Improvement Collaborative. Minds Matter. Toolkit. for You and Your Family. This is the property of
Minds Matter Ohio Psychotropic Medication Quality Improvement Collaborative Minds Matter Toolkit for You and Your Family This is the property of About Minds Matter Minds Matter is a project to help teens,
More informationGuide to Psychiatric Medications for Children and Adolescents
Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists
More information4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies
Child & Adolescent Behavioral Medicine & Medication Therapies Brian J Cowles, PharmD Associate Professor of Pharmacy Practice Albany College of Pharmacy & Health Sciences; Vermont Campus Behavioral Medicine
More informationCreating Partnerships. Laine Young-Walker, MD
Creating Partnerships Laine Young-Walker, MD Psychiatry is the medical specialty devoted to the study, diagnosis, treatment and prevention of mental disorders. Medical school >>>four years of residency
More information11/2/2016 INSIDE THE MIND OF A CHILD PSYCHIATRIST: PROBLEM BEHAVIORS IN CHILDREN WITH AUTISM FACULTY DISCLOSURE
FACULTY DISCLOSURE INSIDE THE MIND OF A CHILD PSYCHIATRIST: PROBLEM BEHAVIORS IN CHILDREN WITH AUTISM KristinDawson, MD Assistant Professor University of Kentucky No commercial conflicts of Interest Salary
More information3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM. Autism Spectrum Disorder
Cynthia King, MD Associate Professor of Psychiatry UNMSOM Autism Spectrum Disorder 1 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive
More information3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM
Cynthia King, MD Associate Professor of Psychiatry UNMSOM 1 2 Autism Spectrum Disorder 3 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive
More informationMental Illness. Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling
Mental Illness Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling Moodiness Changing Bodies Narcissism Self-Esteem Ignorant Naïve Insecure Self-Centered Independent Adolescence Disorders Affecting
More informationIMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members
IMPORTANT NOTICE Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members These changes apply only to members covered under the DC Healthcare Alliance program Alliance
More informationMedications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation
Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral
More informationTreat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused
Psychiatric Drugs Psychiatric Drugs Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally or abused Benzodiazepines
More informationINFORMATION PAPER: INTRODUCING THE NEW DSM-5 DIAGNOSTIC CRITERIA FOR AUTISM SPECTRUM DISORDER
INFORMATION PAPER: INTRODUCING THE NEW DSM-5 DIAGNOSTIC CRITERIA FOR AUTISM SPECTRUM DISORDER What is the DSM-5? The Diagnostic and Statistical Manual of Mental Disorders (the DSM) is developed by the
More informationBehavioral Health. Behavioral Health. Prescribing Guidelines
Behavioral Health Behavioral Health Prescribing Guidelines Attention Deficit/Hyperactivity Disorder (ADHD) Start with a first line medication, either from the methylphenidate or dextroamphetamine-amphetamine
More informationReview of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)
Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder
More informationBrief Notes on the Mental Health of Children and Adolescents
Brief Notes on the Mental Health of Children and Adolescents The future of our country depends on the mental health and strength of our young people. However, many children have mental health problems
More informationWe ll Be Discussing. Pregnancy 4/24/2013
Joe Wegmann, PD, LCSW The PharmaTherapist Joe@ThePharmaTherapist.com 504.587.9798 www.pharmatherapist.com Are you receiving our free monthly e-newsletter? We ll Be Discussing The safety and efficacy track
More informationAutism Spectrum Disorder What is it?
Autism Spectrum Disorder What is it? Robin K. Blitz, MD Resident Autism Diagnostic Clinic Lecture Series #1 Learning Objectives What can we talk about in 20 minutes? What is Autism? What are the Autism
More informationPSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer
PSYCHIATRIC DRUGS Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally
More informationPediatric Psychopharmacology
Pediatric Psychopharmacology General issues to consider. Pharmacokinetic differences Availability of Clinical Data Psychiatric Disorders can be common in childhood. Early intervention may prevent disorders
More informationAutism Spectrum Disorder What is it? Robin K. Blitz, MD Resident Autism Diagnostic Clinic Lecture Series #1
Autism Spectrum Disorder What is it? Robin K. Blitz, MD Resident Autism Diagnostic Clinic Lecture Series #1 Learning Objectives What can we talk about in 20 minutes? What is Autism? What are the Autism
More informationCHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX
A Adderall Counterfeit, 31 addiction, internet CBT, 55 ADHD Adjunctive Guanfacine, 11 Counterfeit Adderall, 31 Developmental Trajectory and Risk Factors, 5 Dopamine Transporter Alterations, 14 Extended-Release
More informationAttention Deficit Hyperactivity Disorder State of the Art. Christopher Okiishi, MD
Attention Deficit Hyperactivity Disorder State of the Art Christopher Okiishi, MD What is ADHD? Three subtypes: Inattentive (under diagnosed, esp. in girls) Hyperactive Impulsive Combined Impairments must
More informationHumberto Nagera M.D. Director, The Carter-Jenkins Center Psychoanalyst, Children, Adolescents and Adults Professor of Psychiatry at USF Professor
The Carter Jenkins Center presents 1 Humberto Nagera M.D. Director, The Carter-Jenkins Center Psychoanalyst, Children, Adolescents and Adults Professor of Psychiatry at USF Professor Emeritus of Psychiatry
More informationAttention Deficit Hyperactivity Disorder (ADHD) in Children under Age 6
in Children under Age 6 Level 0 Conduct comprehensive assessment and provide psychoeducation about ADHD, including clearly defined treatment expectations. Consider co-morbid developmental language disorder,
More informationManaging the Behavior Problems of Children With Fragile X Syndrome by Using Medication Ave M. Lachiewicz, MD, Duke University Medical Center
Managing the Behavior Problems of Children With Fragile X Syndrome by Using Medication Ave M. Lachiewicz, MD, Duke University Medical Center Abstract: The majority of boys and many girls with fragile X
More information7/9/2013. Psychiatric medication treatment in children and adolescents: The good, the bad and the ugly. What ADHD is
Psychiatric medication treatment in children and adolescents: The good, the bad and the ugly Gabrielle A. Carlson, MD Professor of Psychiatry and Pediatrics Director, Child and Adolescent Psychiatry Stony
More informationAUTISM SPECTRUM DISORDER: DSM-5 DIAGNOSTIC CRITERIA. Lisa Joseph, Ph.D.
AUTISM SPECTRUM DISORDER: DSM-5 DIAGNOSTIC CRITERIA Lisa Joseph, Ph.D. Autism Spectrum Disorder Neurodevelopmental disorder Reflects understanding of the etiology of disorder as related to alterations
More informationAD/HD is a mental disorder, and it often lasts from
short version10 WHAT WE KNOW Managing Medication for Adults with AD/HD AD/HD is a mental disorder, and it often lasts from childhood into adulthood. Medication is the basic part of treatment for adults.
More informationAutism Spectrum Disorder: A Primer for PCPs
Autism Spectrum Disorder: A Primer for PCPs Learning Objectives 1. Define current ASD diagnostic criteria 2. Identify ASD screening tools, including the M-CHAT-R/F 3. Describe treatments/interventions
More informationADHD and. Shaw Wendi Fortuchang, M.D. Board certified in Child & Adolescent, Adult, and Forensic Psychiatry
ADHD and Beyond Shaw Wendi Fortuchang, M.D. Board certified in Child & Adolescent, Adult, and Forensic Psychiatry Overview Use of medications in children How do medications work in the brain? Risperdal?
More informationAutism Spectrum Disorder What is it?
Autism Spectrum Disorder What is it? Robin K. Blitz, MD Director, Developmental Pediatrics Resident Autism Diagnostic Clinic Lecture Series #1 Learning Objectives What can we talk about in 20 minutes?
More informationPsychopharmacology for Treatment of ADHD and ADHD with other co-existing psychiatric condition
Psychopharmacology for Treatment of ADHD and ADHD with other co-existing psychiatric condition Presented by Cat Dang, D.O Medical Director - Insightful Minds, Inc. Objectives Evaluation process Pharmacology
More informationASD Autism Spectrum Disorder
Psychopharmacology and Autism Spectrum Disorder Bennett L. Leventhal, MD Professor Department of Psychiatry University of California, San Francisco Sources of Research Support NIH Simons Foundation Janssen
More informationUsing Drugs to Improve the Behavior of People with Autism: A Skeptical Appraisal. Alan Poling, Ph.D., BCBA-D Western Michigan University
Using Drugs to Improve the Behavior of People with Autism: A Skeptical Appraisal Alan Poling, Ph.D., BCBA-D Western Michigan University In a 2010 study of 60,641 children Mandell et al. found that: 56%
More informationPsychiatric medication treatment in children and adolescents:
Psychiatric medication treatment in children and adolescents: The good, the bad and the ugly Gabrielle A. Carlson, MD Professor of Psychiatry and Pediatrics Director, Child and Adolescent Psychiatry Stony
More informationThe Benefits and Limitations of Medication Treatment for Executive Dysfunctions and ADHD
The Benefits and Limitations of Medication Treatment for Executive Dysfunctions and ADHD Damon Korb, MD Behavioral and Developmental Pediatrician Director of the Center for Developing Minds Los Gatos,
More informationTreatment of Children with Mental Disorders
Treatment of Children with Mental Disorders Children are in a state of rapid change and growth during their developmental years. Diagnosis and treatment of mental disorders must be viewed with these changes
More informationFact Sheet 8. DSM-5 and Autism Spectrum Disorder
Fact Sheet 8 DSM-5 and Autism Spectrum Disorder A diagnosis of autism is made on the basis of observed behaviour. There are no blood tests, no single defining symptom and no physical characteristics that
More informationASD (hyperactivity) 3 rd LINE TREATMENT Initial liquid dose mg 2. - ADHD symptoms without sleep
Generic Name Label Name Dosing by Disorder RITALIN, RITALIN LA, CONCERTA, METADATE ER, 2 ND LINE TREATMENT 2 ND LINE TREATMENT METADATE CD, MPH ER, Initial liquid dose 1-5 mg 1,2 Initial liquid dose 1-5mg
More informationPiecing the Puzzle Together: Pharmacologic Approaches to Behavioral Management in Autism Spectrum Disorder
Piecing the Puzzle Together: Pharmacologic Approaches to Behavioral Management in Autism Spectrum Disorder Hannah Sauer, PharmD PGY1 Pediatric Pharmacy Resident Mayo Clinic 2015 MFMER slide-1 Objectives
More informationChild & Adolescent Psychiatry (a brief overview)
Child & Adolescent Psychiatry (a brief overview) Lance Feldman, MD, FAPA, MBA, BSN Vice Chair Clinical Affairs, Department of Psychiatry Affiliate Clinical Assistant Professor, University of South Carolina
More informationWhat are the most common signs of ADHD? And what are the most common medication interventions?
What are the most common signs of ADHD? And what are the most common medication interventions? Bennett Gertz, MD, FAAP Developmental Behavioral Pediatrician Children s Developmental Health Services Albertina
More informationNational Professional Development Center on Autism Spectrum Disorders
National Professional Development Center on Autism Spectrum Disorders Parent and Child Information Questionnaire Thank you for taking time to complete this questionnaire. This information will help us
More informationDevelopmental Disorders also known as Autism Spectrum Disorders. Dr. Deborah Marks
Pervasive Developmental Disorders also known as Autism Spectrum Disorders Dr. Deborah Marks Pervasive Developmental Disorders Autistic Disorder ( Autism) - Kanner Asperger Syndrome Pervasive Developmental
More informationCommon Psychiatric Conditions in Children. Steven Klamerus, M.D. Child and Adolescent Psychiatrist Marquette General Hospital
Common Psychiatric Conditions in Children Steven Klamerus, M.D. Child and Adolescent Psychiatrist Marquette General Hospital (Child) Psychiatry is different Phenomenological diagnoses verses pathologic
More informationBig Lots Behavioral Health. Prescribing Guidelines for Behavioral Health
Big Lots Behavioral Health Prescribing Guidelines for Behavioral Health Prescribing for Behavioral Health This document was developed by Nationwide Children s Hospital in conjunction with Partners For
More informationCriteria for Child Psychiatrist on the Use of Selected Psychotropic Medications in Children & Adolescents
Criteria for Child Psychiatrist on the Use of Selected Psychotropic Medications in Children & Adolescents DRUG NAME INDICATIONS / ACCEPTABLE USES PRIOR STIMULANT/ADHD DRUGS Daytrana (methylphenidate) ADHD
More informationBob Klaehn, M.D. Bob Klaehn, M.D. October 3, /30/14
Bob Klaehn, M.D. October 3, 2014 1 Bob Klaehn, M.D. Medical Director, Arizona Division of Developmental Disabilities since 2001 Faculty, MIHS Child Psychiatry Residency Program Child Psychiatrist, District
More informationAutism. Autism and autistic spectrum
Autism Autism is a disorder that affects the way a person communicates with and relates to other people. Most (but not all) people with autism also have a learning disability. People with autism need specialist
More informationAn Autism Primer for the PCP: What to Expect, When to Refer
An Autism Primer for the PCP: What to Expect, When to Refer Webinar November 9, 2016 John P. Pelegano MD Chief of Pediatrics Hospital for Special Care Disclosures None I will not be discussing any treatments,
More informationAutism Diagnosis and Management Update. Outline. History 11/1/2013. Autism Diagnosis. Management
Autism Diagnosis and Management Update Cathleen Small, PhD, BCBA-D Developmental Behavioral Pediatrics Maine Medical Partners Outline Autism Diagnosis Brief history New, DSM-5 diagnostic criteria Expressed
More informationAutism Update: Classification & Treatment
Autism Update: Classification & Treatment Dana Battaglia, Ph.D., CCC-SLP NYSUT Professional Issues Forum on Healthcare April 26 th, 2013 10:30-12:30 1 Who is here today? Our Goals for This Morning Introduce
More informationAutism Spectrum Disorders. Erin McFarland, M.Ed., LPC November 1, 2012
Autism Spectrum Disorders Erin McFarland, M.Ed., LPC November 1, 2012 What are Autism Spectrum Disorders (ASD)? Range of complex neurodevelopmental disorders characterized by social impairments, communication
More informationDisclosures. Autism Society of Wisconsin. Case 2. Case 1. Case 3. Case 4 3/29/2018. Medication treatment for people with Autism Spectrum Disorder
Medication treatment for people with Autism Spectrum Disorder Autism Society of Wisconsin April 20, 2018 Richard P. Barthel, M.D. Disclosures In accordance with the ACCME policy on relevant financial disclosure,
More informationPsychopharmacology: An Overview
Psychopharmacology: An Overview John Tanquary, M.D. Clinical Assistant Professor Department of Psychiatry Upstate Medical University Psychpharmacology Consultant Le Moyne College Syracuse University Financial
More informationPL CE LIVE February 2011 Forum
February 2011 PL CE LIVE Kristin W. Weitzel, Pharm.D., CDE, FAPhA Associate Editor and Director of Editorial Projects Pharmacist s Letter/Prescriber s Letter Atypical Antipsychotics Atypical Antipsychotics
More informationPharmacologic Management of ADHD
Pharmacologic Management of ADHD CHADD Presentation April 13, 2015 Peter J Chung, MD, FAAP Developmental-Behavioral Pediatrician* Assistant Clinical Professor of Pediatrics University of California Irvine
More informationTools that make a difference in mental health symptoms of autistic spectrum children Sumru Bilge-Johnson M.D. Program Director of Child Psychiatry
Tools that make a difference in mental health symptoms of autistic spectrum children Sumru Bilge-Johnson M.D. Program Director of Child Psychiatry Fellowship Associate Professor, Child Psychiatry NEOMED
More informationOhio Psychotropic Medication Quality Improvement Collaborative. Minds Matter. Toolkit. for Youth and Caregivers. This is the property of
Minds Matter Ohio Psychotropic Medication Quality Improvement Collaborative Minds Matter Toolkit for Youth and Caregivers This is the property of About Minds Matter Minds Matter is a statewide project
More informationKelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009
Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009 List the antipsychotics most often prescribed Compare and contrast the use and adverse effects experienced in the pediatric
More informationPSYCHIATRY INTAKE FORM
Please complete all information on this form. PSYCHIATRY INTAKE FORM Name Date Date of Birth Primary Care Physician Current Therapist/Counselor What are the problem(s) for which you are seeking help? 1.
More informationCHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XV, 2013 INDEX
A acceptance and commitment therapy Posttraumatic Stress, 69 ADHD Adjunctive Fatty Acids, 5 Adjunctive Guanfacine Pharmacokinetics, 27 Amantadine, 21 Atomoxetine, 23 Cancer Risk, 31 CBT for Comorbid Anxiety,
More informationBig Lots Behavioral Health. Prescribing Guidelines for Behavioral Health
Big Lots Behavioral Health Prescribing Guidelines for Behavioral Health Prescribing for Behavioral Health This document was developed by Nationwide Children s Hospital in conjunction with Partners For
More informationPsychotropic Medications in Children and Adolescents: Guide for Use and Monitoring
Psychotropic Medications in Children and Adolescents: Guide for Use and This document was developed by Community Care of North Carolina with the assistance of the Medication Management Workgroup of the
More informationChild and Adolescent Psychopharmacology Made Simple (2nd edition)
Child and Adolescent Psychopharmacology Made Simple (2nd edition) Questions from chapter 1 1) It is likely that the majority of emotional suffering experienced by youngsters is related to a) genetics b)
More informationMood Disorders for Care Coordinators
Mood Disorders for Care Coordinators David A Harrison, MD, PhD Assistant Professor, Dept of Psychiatry & Behavioral Sciences University of Washington School of Medicine Introduction 1 of 3 Mood disorders
More informationIntroductory discussion
Billina R. Shaw, MD Assistant Professor University of Maryland School of Medicine Department of Psychiatry Division of Child and Adolescent Psychiatry Introductory discussion Prescribing trends in foster
More informationAutism and Other Autism Spectrum Disorders (ASDs) or Pervasive Developmental Disorders (PDDs)
June 11, 2008 Autism and Other Autism Spectrum Disorders (ASDs) or Pervasive Developmental Disorders (PDDs) Institute for Development of Mind and Behavior Masataka Ohta MD (Email: mohta-dmb@nifty.com)
More informationPerspective Truth on ADHD & Medications. Thomas L. Matthews, M.D. Associate Dean of Student Affairs Professor of Psychiatry
Perspective Truth on ADHD & Medications Thomas L. Matthews, M.D. Associate Dean of Student Affairs Professor of Psychiatry Disclosures National Institute of Health ADHD and Aggression Study Co- Investigator
More informationDealing with a Mental Health Crisis
Dealing with a Mental Health Crisis Information and Resources for First Responders P... PROFESSIONAL WHAT NAMI DOES NAMI Minnesota is a statewide 501(c)(3) grassroots nonprofit organization dedicated to
More informationMental Health & Your Teen Tools, Strategies & Resources
3 rd Annual 22q11DS Family Conference Mental Health & Your Teen Tools, Strategies & Resources Dr. Claire De Souza Child & Adolescent Psychiatrist Medical Director, Consultation-Liaison Psychiatry Program
More informationJennifer Zarcone. Kennedy Krieger Institute and Johns Hopkins School of Medicine
Jennifer Zarcone Kennedy Krieger Institute and Johns Hopkins School of Medicine 1 2 Estimated that between 20% to 45% of people with autism and ID are taking psychotropic medication 14% 30% are taking
More informationTreating Disruptive Behavior Disorders in Children and Teens. A Review of the Research for Parents and Caregivers
Treating Disruptive Behavior Disorders in Children and Teens A Review of the Research for Parents and Caregivers e Is This Information Right for Me? This information is for you if: A health care professional*
More informationNew Patient Questionnaire
4 Embarcadero Center, Suite 1400, San Francisco, CA 94111 (415) 926-7774 phone; (415) 591-7760 office@sanfranciscopsych.com New Patient Questionnaire Thank you for trusting San Francisco Psychiatry with
More informationHealth and Development in XYY Syndrome
Health and Development in XYY Syndrome Jeannie Visootsak, MD Emory University Slides contribution from Nicole Tartaglia, MD Outline Medical Problems in XYY Development and Neurodevelopmental Disorders
More information2013 Virtual AD/HD Conference 1
Medication for & Coexisting Conditions Part 2 Dr. Kenny Handelman Child, Adolescent & Adult Psychiatrist Halton Healthcare Adjunct Professor of Psychiatry, University of Western Ontario www.drkenny.com
More informationChallenging ASD Cases November 11, Melanie Penner, MD, MSc, Mohammad Zubairi, MD, MEd,
Challenging ASD Cases November 11, 2017 Melanie Penner, MD, MSc, FRCPC @drmelpenner Mohammad Zubairi, MD, MEd, FRCPC @md_mszubairi Learning Objectives By the end of this workshop, participants will: 1)
More informationOverview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials
SPEAKER NOTES Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials Summarized by Thomas T. Thomas New psychotropic medications are coming on the
More informationPractical Psychopharmacology for More Complex Mental Health Presentations
MINISTRY OF CHILDREN AND YOUTH SERVICES Practical Psychopharmacology for More Complex Mental Health Presentations Part 1: Stimulants Dr. Ajit Ninan & Joel Lamoure 1 Practical Psychopharmacology for More
More information11/11/2018. The ABCs of Medication Management for Autism Spectrum Disorder. ABC Logging (FBA) First. ABC Logging HOW TO COMPLEMENT BEHAVIORAL THERAPY
The ABCs of Medication Management for Autism Spectrum Disorder OR HOW TO COMPLEMENT BEHAVIORAL THERAPY ABC Logging (FBA) First We need to know what, when, where and why behaviors happen. Antecedent: What
More informationThe Clinical Progress of Autism Spectrum Disorders in China. Xi an children s hospital Yanni Chen MD.PhD
The Clinical Progress of Autism Spectrum Disorders in China Xi an children s hospital Yanni Chen MD.PhD Conception The autism spectrum disorders (ASDs) are neurodevelopmental disability characterized by
More informationDSM 5 Criteria to Diagnose Autism
DSM 5 Criteria to Diagnose Autism Patient Name Patient Date of Birth Patient Health Plan Provider Name and Credential Date of Exam Only a doctoral level clinician (MD, PhD, and/or PsyD) can complete this
More informationFrom Diagnostic and Statistical Manual of Mental Disorders: DSM IV
From Diagnostic and Statistical Manual of Mental Disorders: DSM IV (I) A total of six (or more) items from (A), (B), and (C), with at least two from (A), and one each from (B) and (C) (A) qualitative impairment
More informationAutism beyond childhood. The Challenges
Autism beyond childhood The Challenges Why ASD and Why Now? Prevalence Historically emphasis has been on childhood Adults fall through cracks Poor services Government responses Pervasive Developmental
More informationRichard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA
*We are not accepting any New Patients who are currently taking any controlled pain medications *We are *Note: not completion accepting of the any following New Patients paperwork who and Initial are Screening
More informationUnderstanding Autism. Julie Smith, MA, BCBA. November 12, 2015
Understanding Autism Julie Smith, MA, BCBA November 12, 2015 2 Overview What is Autism New DSM-5; changes to diagnosis Potential causes Communication strategies Managing difficult behaviors Effective programming
More informationMental Health Medications. National Institute of Mental Health. U.S. Department of HealtH and HUman ServiceS National Institutes of Health
Mental Health Medications National Institute of Mental Health U.S. Department of HealtH and HUman ServiceS National Institutes of Health Contents Mental Health Medications...1 What are psychiatric medications?...1
More information